Sustainable social distancing through facemask use and testing during the Covid-19 pandemic

Diego Chowell; Kimberlyn Roosa; Ranu Dhillon; Gerardo Chowell; Devabhaktuni Srikrishna

doi:10.1101/2020.04.01.20049981

Abstract

We investigate how individual protective behaviors, different levels of testing, and isolation influence the transmission and control of the COVID-19 pandemic. Based on an SEIR-type model incorporating asymptomatic but infectious individuals (40%), we show that the pandemic may be readily controllable through a combination of testing, treatment if necessary, and self-isolation after testing positive (TTI) of symptomatic individuals together with social protection (e.g., facemask use, handwashing). When the basic reproduction number, R0, is 2.4, 65% effective social protection alone (35% of the unprotected transmission) brings the R below 1. Alternatively, 20% effective social protection brings the reproduction number below 1.0 so long as 75% of the symptomatic population is covered by TTI within 12 hours of symptom onset. Even with 20% effective social protection, TTI of 1 in 4 symptomatic individuals can substantially 'flatten the curve' cutting the peak daily incidence in half.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

none

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes